12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic resection is now a standard treatment for early gastrointestinal cancers without regional lymph node metastasis. High-definition white light endoscopy, chromoendoscopy, and image-enhanced endoscopy such as narrow band imaging are performed to assess the edge and depth of early gastrointestinal cancers for delineation of resection boundaries and prediction of the possibility of lymph node metastasis before the decision of endoscopic resection. Endoscopic mucosal resection and/or endoscopic submucosal dissection can be performed to remove early gastrointestinal cancers completely by <i>en bloc</i> fashion. Histopathological evaluation should be carefully made to investigate the presence of risk factors for lymph node metastasis such as depth of cancer invasion and lymphovascular invasion. Additional treatment such as radical surgery with regional lymphadenectomy should be considered if the endoscopically resected specimen shows risk factors for lymph node metastasis. This is the first Korean clinical practice guideline for endoscopic resection of early gastrointestinal cancer. This guideline was developed by using mainly de novo methods and encompasses endoscopic management of superficial esophageal squamous cell carcinoma, early gastric cancer, and early colorectal cancer. This guideline will be revised as new data on early gastrointestinal cancer are collected.

          Related collections

          Most cited references237

          • Record: found
          • Abstract: found
          • Article: not found

          Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

          This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system 1 2 was adopted to define the strength of recommendations and the quality of evidence.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

            Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resectable esophageal and esophagogastric junction (EGJ) cancer, and randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival. Targeted therapies including trastuzumab, ramucirumab, and pembrolizumab have produced encouraging results in the treatment of patients with advanced or metastatic disease. Multidisciplinary team management is essential for all patients with esophageal and EGJ cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

              The relation between Helicobacter pylori infection and gastric cancer has been proven in epidemiological studies and animal experiments. Our aim was to investigate the prophylactic effect of H pylori eradication on the development of metachronous gastric carcinoma after endoscopic resection for early gastric cancer. In this multi-centre, open-label, randomised controlled trial, 544 patients with early gastric cancer, either newly diagnosed and planning to have endoscopic treatment or in post-resection follow-up after endoscopic treatment, were randomly assigned to receive an H pylori eradication regimen (n=272) or control (n=272). Randomisation was done by a computer-generated randomisation list and was stratified by whether the patient was newly diagnosed or post-resection. Patients in the eradication group received lansoprazole 30 mg twice daily, amoxicillin 750 mg twice daily, and clarithromycin 200 mg twice daily for a week; those in the control group received standard care, but no treatment for H pylori. Patients were examined endoscopically at 6, 12, 24, and 36 months after allocation. The primary endpoint was diagnosis of new carcinoma at another site in the stomach. Analyses were by intention to treat. This trial is registered with the UMIN Clinical Trials Registry, number UMIN000001169. At 3-year follow-up, metachronous gastric carcinoma had developed in nine patients in the eradication group and 24 in the control group. In the full intention-to-treat population, including all patients irrespective of length of follow-up (272 patients in each group), the odds ratio for metachronous gastric carcinoma was 0.353 (95% CI 0.161-0.775; p=0.009); in the modified intention-to-treat population, including patients with at least one post-randomisation assessment of tumour status and adjusting for loss to follow-up (255 patients in the eradication group, 250 in the control group), the hazard ratio for metachronous gastric carcinoma was 0.339 (95% CI 0.157-0.729; p=0.003). In the eradication group, 19 (7%) patients had diarrhoea and 32 (12%) had soft stools. Prophylactic eradication of H pylori after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma. Hiroshima Cancer Seminar Foundation.
                Bookmark

                Author and article information

                Journal
                Clin Endosc
                Clin Endosc
                CE
                Clinical Endoscopy
                Korean Society of Gastrointestinal Endoscopy
                2234-2400
                2234-2443
                March 2020
                30 March 2020
                : 53
                : 2
                : 142-166
                Affiliations
                [1 ]Department of Gastroenterology, Hanyang University Guri Hospital, Guri, Korea
                [2 ]Department of Gastroenterology, Asan Medical Center, Seoul, Korea
                [3 ]Department of Gastroenterology, Inje University Ilsan Paik Hospital, Goyang, Korea
                [4 ]Department of Gastroenterology, Yonsei University Gangnam Severance Hospital, Seoul, Korea
                [5 ]Department of Gastroenterology, Inje University Busan Paik Hospital, Busan, Korea
                [6 ]Department of Gastroenterology, Samsung Medical Center, Seoul, Korea
                [7 ]Department of Gastroenterology, Yeungnam University Medical Center, Daegu, Korea
                [8 ]Department of Gastroenterology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea
                [9 ]Department of Gastroenterology, Seoul National University Hospital, Seoul, Korea
                [10 ]Department of Gastroenterology, Yonsei University Severance Hospital, Seoul, Korea
                [11 ]Department of Gastroenterology, Kyung Hee University Hospital at Gangdong, Seoul, Korea
                [12 ]Center for Colorectal Cancer, National Cancer Center, Goyang, Korea
                [13 ]Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea
                [14 ]National Evidence-based Healthcare Collaborating Agency, Seoul, Korea
                [15 ]Center for Gastric Cancer, National Cancer Center, Goyang, Korea
                [16 ]Department of Gastroenterology, Chosun University Hospital, Gwangju, Korea
                [17 ]Department of Gastroenterology, Cha University Bundang Medical Center, Seongnam, Korea
                [18 ]Department of Gastroenterology, Jeonbuk National University Hospital, Jeonju, Korea
                [19 ]Department of Gastroenterology, Korea University Anam Hospital, Seoul, Korea
                Author notes
                Correspondence: Jong Yeul Lee Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-1613, Fax: +82-31-920-2799, E-mail: jylee@ 123456ncc.re.kr
                Jeong-Sik Byeon Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3905, Fax: +82-2-3010-6157, E-mail: jsbyeon@ 123456amc.seoul.kr
                [*]

                These authors contributed equally to this study.

                Author information
                http://orcid.org/0000-0003-3824-3481
                http://orcid.org/0000-0001-7756-2704
                http://orcid.org/0000-0003-0505-2697
                http://orcid.org/0000-0002-9198-3326
                http://orcid.org/0000-0003-0861-2792
                http://orcid.org/0000-0001-7471-1305
                http://orcid.org/0000-0001-7221-7506
                http://orcid.org/0000-0001-7669-1213
                http://orcid.org/0000-0001-5159-357X
                http://orcid.org/0000-0002-2517-4109
                http://orcid.org/0000-0001-8018-0010
                http://orcid.org/0000-0003-4271-7205
                http://orcid.org/0000-0002-8988-7423
                http://orcid.org/0000-0002-0039-7728
                http://orcid.org/0000-0003-2764-9339
                http://orcid.org/0000-0002-1667-7986
                http://orcid.org/0000-0002-2424-9965
                http://orcid.org/0000-0001-7225-3152
                http://orcid.org/0000-0001-8709-5097
                http://orcid.org/0000-0002-9581-2655
                http://orcid.org/0000-0002-7182-5806
                http://orcid.org/0000-0002-0758-1923
                http://orcid.org/0000-0002-5539-361X
                Article
                ce-2020-032
                10.5946/ce.2020.032
                7137564
                32252507
                dc82bcc7-d873-4716-b35a-1c745ad29a31
                Copyright © 2020 Korean Society of Gastrointestinal Endoscopy

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 January 2020
                : 22 March 2020
                : 23 March 2020
                Categories
                Review

                Radiology & Imaging
                early colorectal cancer,early gastric cancer,endoscopic resection,guideline,superficial esophageal squamous cell carcinoma

                Comments

                Comment on this article